Oppenheimer & Co’s Myovant Sciences Ltd. MYOV Stock Holding History

Oppenheimer & Co’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,450	Closed	-$206K	–	1512
2020 Q4	$206K	Buy	+7,450	New	+$145K	﹤0.01%	1239

Other funds holding MYOV

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

Oppenheimer & Co's MYOV Position: Q1 2021 in Review

Oppenheimer & Co sold out of Myovant Sciences Ltd. (MYOV) in Q1 2021, closing a stake of 7,450 shares — an estimated $206K sold.

Oppenheimer & Co first reported a position in MYOV in Q4 2020 and held it in 1 quarter. The position peaked at $206K in Q4 2020. 104 funds tracked by Wall St. Rank hold MYOV as of Q1 2021.

Oppenheimer & Co reported no remaining Myovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Oppenheimer & Co sold 7,450 Myovant Sciences Ltd. shares in Q1 2021, an estimated $206K.
Oppenheimer & Co first reported a position in Myovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
Oppenheimer & Co's Myovant Sciences Ltd. position peaked at $206K in Q4 2020.
104 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2021.

Based on Oppenheimer & Co's 13F filing for Q1 2021, filed 10 May 2021.